Company performance
Add to research
Current Price
as of Mar 20, 2025$149.63
P/E Ratio
N/A
Market Cap
$20.43B
Description
Add to research
Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT). The company was founded by Matthew Rabinowitz and Jonathan Sheena in November 2003 and is headquartered in Austin, TX.
Metrics
Add to research
Overview
- HQAustin, TX
- SectorHealth Technology
- IndustryMedical Specialties
- TickerNTRA
- Price$149.63-0.82%
Trading Information
- Market cap$20.43B
- Float94.74%
- Average Daily Volume (1m)2,515,498
- Average Daily Volume (3m)1,660,522
- EPS-$1.53
Company
- Revenue$1.70B
- Rev growth (1yr)56.75%
- Net income-$190.43M
- Gross margin60.30%
- EBITDA margin-11.27%
- EBITDA-$191.33M
- EV$18.96B
- EV/Revenue11.17
- P/EN/A
- P/S11.00
- P/B16.60
- Debt/Equity15.65
Documents
Add to research
SEC Filings
Earnings Calls